Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Noelia Alvarez-Rivas"'
Autor:
Noelia Álvarez-Rivas, Gloria Lugo-Rodríguez, Jose Ramón Maneiro, Carlota Iñiguez-Ubiaga, Rafael Benito Melero-Gonzalez, Tania Iglesias-Cabo, Loreto Carmona, Carlos García-Porrúa, Francisco Javier de Toro-Santos
Publikováno v:
Bone Reports, Vol 21, Iss , Pp 101772- (2024)
Introduction: Tumor-induced osteomalacia (TIO), is a rare acquired paraneoplastic syndrome characterized by defective bone mineralization, caused by the overproduction of fibroblast growth factor 23 (FGF23) by a tumor. Material and methods: We conduc
Externí odkaz:
https://doaj.org/article/edf557c5f34b434c9276d22478073b85
Autor:
Noelia Alvarez-Rivas, Francisca Sivera, Susana Romero-Yuste, Carles Galisteo, Santos Castañeda, Monica Calderón-Goercke, Elena Becerra-Fernández, Ignacio Villa, José L. Hernández, Vicente Aldasoro, Diana Prieto-Peña, Eugenio de Miguel, Rafael Melero, Miguel A. González-Gay, Ricardo Blanco, Eva Perez-Pampin, Catalina Gomez-Arango, Javier Narváez, Marcelino Revenga, Clara Moriano
Publikováno v:
Seminars in arthritis and rheumatism. 51(2)
Objective To compare the efficacy and safety of TCZ in monotherapy (TCZMONO) vs. combined with conventional immunosuppressive drugs (TCZCOMBO) in Giant Cell Arteritis (GCA) in a clinical practice scenario. Methods Multicenter study of 134 patients wi
Autor:
Beatriz Arca, J. C. Nieto González, C. Fernández, Javier Loricera, A. García, Eva Perez-Pampin, Valvanera Pinillos, Noelia Alvarez-Rivas, Carlos Fernández-López, C. Hidalgo, Rafael Melero, Alejandro Gallego, Iñigo Rúa-Figueroa, Roman Blanco, A. García-Valle, J.L. Andreu Sánchez, I. Villa-Blanco, S. Manrique Arija, J. P. Valdivieso-Achá, Marcelino Revenga, O. Maíz, Clara Moriano, M. A. González-Gay, E. Salgado-Pérez, Vicente Aldasoro, Eva Galíndez-Agirregoikoa, P. Moya, Enrique Raya, J. Sanchez, P. Vela-Casasempere, E. De Miguel, J. R. De Dios, M. D. Boquet, Francisca Sivera, A. Juan-Mas, Ruth López-González, L. Sanchez-Bilbao
Publikováno v:
Annals of the Rheumatic Diseases. 80:34.2-35
Background:Giant cell arteritis (GCA) may be divided into cranial, and extracranial GCA. Tocilizumab (TCZ) has shown efficacy and safety in GCA and other large-vessel vasculitis (LVV) (1-5).Objectives:To compare the efficacy of TCZ in cranial and ext
Autor:
C. Fernández-Díaz, S. García Morillo, C. Romero-Gómez, Raquel Rosa, Roman Blanco, M. Freire González, Cristina Fernández-Carballido, Norberto Ortego, Pilar Bernabeu, F.M. Ortiz Sanjuan, E. Rubio Romero, Carlos Fernández-López, N. Fernández-Llanio, M. J. Montesa, M. A. González-Gay, S. Castañeda, J. L. Alonso Valdivieso, B. González-Alvarez, J.A. Narváez, S. Manrique Arija, Juan Salvatierra, Susana Romero-Yuste, E. Salgado-Pérez, P. Vela-Casasempere, J. Mendizabal, B. Bravo, Diana Prieto-Peña, P. S. Laura, José-Luis Callejas-Rubio, Noelia Alvarez-Rivas, Belén Atienza-Mateo, Sheila Melchor, C. Hidalgo, I. Pérez de Pedro, E. De Miguel, Miguel Minguez, Javier Loricera, R. Gómez de la Torre, P. Moya, Roser Solans-Laqué, Santiago Rodríguez Suárez, M. Delgado Sanchez
Publikováno v:
Annals of the Rheumatic Diseases. 80:1208.2-1209
Background:Tocilizumab (TCZ) has shown to be effective for large vessel vasculitis including Takayasu arteritis (TAK) (1-3). Most evidence in TAK comes from Asian patients. However, white patients seem to have different clinical and prognostic featur
Autor:
Vicente Aldasoro, J. I. Banzo, Noelia Alvarez-Rivas, Luisa Marena Rojas, Santos Castañeda, Francisca Sivera, N. Fernández-Llanio, J.A. Narváez, Antonio Mera Varela, Eva Galindez, Eva Perez-Pampin, I. Villa-Blanco, Miguel A. González-Gay, Diana Prieto-Peña, Javier Loricera, Monica Calderón-Goercke, Isabel Martínez-Rodríguez, Ricardo Blanco, Susana Romero-Yuste, Elena Aurrecoechea, Roser Solans-Laqué, María Álvarez del Buergo, Catalina Gomez-Arango
Publikováno v:
Poster Presentations.
Autor:
Eugenio de Miguel, José Andrés Román-Ivorra, Eva Perez-Pampin, Ángel García-Manzanares, Monica Calderón-Goercke, Montserrat Corteguera, Luisa Marena Rojas, Alejandro Olivé, Carmen González-Vela, Vicente Aldasoro, I. Villa-Blanco, Norberto Ortego, Cristina Luna-Gomez, Sabela Fernández, Noelia Alvarez-Rivas, Diana Prieto-Peña, Elena Aurrecoechea, Miguel A. González-Gay, Ricardo Blanco, Sara Manrique Arija, Francisca Sivera, J. Luis Hernández, Antonio García, Javier Narváez, Susana Romero-Yuste, Natalia Palmou-Fontana, Santos Castañeda, Paloma Vela-Casasempere, Vanesa Calvo-Río, Toyos Sáenz de Miera, Alfonso Corrales, J Francisco, Marcelino Revenga, Francisco Ortiz-Sanjuán, Carmen Torres-Martín, Elena Becerra-Fernández, Carlos Vázquez, Carmen Ordas-Calvo, Eva Galindez, Beatriz Arca, María Varela-García, Clara Moriano, Eva Salgado-Pérez, Carles Galisteo, Carlos Fernández-López, N. Fernández-Llanio, Carmen Larena, Enrique Raya, Francisco Navarro, Pau Lluch, Javier Loricera, Arantxa Conesa, A. Humbría, Roser Solans-Laqué, Rafael Melero, Raquel Dos-Santos, C. Hidalgo, María Álvarez del Buergo, Juan Carlos Nieto, Catalina Gomez-Arango
Publikováno v:
Saturday, 15 June 2019.
Background Tocilizumab (TCZ) has been approved for the treatment of Giant Cell Arteritis (GCA). It showed to be effective to induce remission, prevent relapses and decrease the cumulative prednisone dose. However, the glucocorticoids are the mainstay
Autor:
Trinidad Pérez Sandoval, O. Maiz-Alonso, Mireia López-Corbeto, Clara Aguilera Cros, P. Vela-Casasempere, Ivan Castellví, José Antonio Bernal-Vidal, C. Delgado-Beltran, R. Castellanos-Moreira, Miguel A. González-Gay, Sergi Ordoñez, Alejandra López Robles, J. Loricera, Santos Castañeda, Ricardo Blanco, Iván Cabezas-Rodríguez, A. Juan-Mas, Alejandro Olive, B. Alvarez-Rodríguez, Natalia Mena-Vázquez, A. Urruticoechea-Arana, Maria Lopez Lasanta, José Luis Andréu Sánchez, C. Fito-Manteca, S Rodiguéz-Garcia, A. Ruibal-Escribano, Gemma Bonilla, J.M. Blanco, Raquel Almodóvar, Susana Romero-Yuste, Noelia Alvarez-Rivas, Luis Marcelino Arboleya Rodríguez, Samantha Rodríguez-Muguruza, Mireia Moreno, Francisco Ortiz-Sanjuán, C. Hidalgo, Eva Salgado-Pérez, Ivette Casafont-Solé, C. González-Montagut Gómez, I. Villa-Blanco, Manuel Moreno, J. Fernández-Melon, M. Rodíguez-Gómez, R. López-Sánchez, Deseada Palma Sánchez, Rosa Expósito, I. Hernández-Rodriguez, Carmen Carrasco-Cubero, Patricia Carreira, C. Fernández-Díaz, Blanca Garcia-Magallon, E. C. Cervantes Pérez, C. Ojeda-Garcia, M. Retuerto-Guerrero
Publikováno v:
Abstracts Accepted for Publication.
Background Rheumatoid arthritis (RA) may associate with Interstitial Lung Disease (ILD). Disease-modifying anti-rheumatic drug (DMARD) or TNF alfa inhibitors (iTNF), had been involved in the ILD development as well as exacerbation of an existing one.
Autor:
Sara Manrique Arija, Pau Lluch, Alejandro Olivé, María Álvarez del Buergo, J. Luis Hernández, Clara Moriano, Juan Carlos Nieto, Javier Loricera, Arantxa Conesa, Marcelino Revenga, Elena Aurrecoechea, Rafael Melero, Vanesa Calvo-Río, Paloma Vela-Casasempere, Miguel A. González-Gay, C. Hidalgo, Catalina Gomez-Arango, Elena Becerra-Fernández, Raquel Dos-Santos, Antonio García, Diana Prieto-Peña, Francisca Sivera, María Varela-García, Carles Galisteo, Natalia Palmou-Fontana, Santos Castañeda, Beatriz Arca, I. Villa-Blanco, Montserrat Corteguera, Eva Salgado-Pérez, A. Humbría, Luisa Marena Rojas, Ricardo Blanco, Norberto Ortego, Roser Solans-Laqué, Francisco Ortiz-Sanjuán, Eugenio de Miguel, Eva Galindez, José Andrés Román-Ivorra, Alfonso Corrales, Enrique Raya, Carlos Vázquez, Carmen Torres-Martín, Ángel García-Manzanares, Francisco Navarro, J Francisco, Monica Calderón-Goercke, Noelia Alvarez-Rivas, Susana Romero-Yuste, Carmen Ordas-Calvo, Carlos Fernández-López, N. Fernández-Llanio, Carmen Larena, Sabela Fernández, Eva Perez-Pampin, Cristina Luna-Gomez, Carmen González-Vela, Vicente Aldasoro, Javier Narváez, Toyos Sáenz de Miera
Publikováno v:
Poster Presentations.
Background In Giant Cell Arteritis (GCA) two dominant cytokine clusters have been linked to disease activity, IL-6 – IL-17 axis (Th17) and IL-12 – IFN γ axis (Th1). The first one related to systemic symptoms and the second route responsible for
Autor:
María Álvarez del Buergo, Raquel Dos-Santos, Susana Romero-Yuste, Juan Carlos Nieto, I. Villa-Blanco, A. Humbría, Clara Moriano, Javier Narváez, Natalia Palmou-Fontana, Catalina Gomez-Arango, Carmen Ordas-Calvo, Ricardo Blanco, Santos Castañeda, Beatriz Arca, Enrique Raya, José Andrés Román-Ivorra, Eva Salgado-Pérez, Roser Solans-Laqué, Pau Lluch, Francisco Ortiz-Sanjuán, Monica Calderón-Goercke, J. Luis Hernández, Javier Loricera, Arantxa Conesa, Carlos Fernández-López, J Francisco, N. Fernández-Llanio, Carmen Larena, Vanesa Calvo-Río, Alejandro Olivé, C. Hidalgo, Carlos Vázquez, Elena Becerra-Fernández, Francisca Sivera, Sara Manrique Arija, Francisco Navarro, Eva Galindez, Marcelino Revenga, Carmen Torres-Martín, Rafael Melero, María Varela-García, Carles Galisteo, Luisa Marena Rojas, Toyos Sáenz de Miera, Norberto Ortego, Diana Prieto-Peña, Eva Perez-Pampin, Noelia Alvarez-Rivas, Eugenio de Miguel, Ángel García-Manzanares, Miguel A. González-Gay, Carmen González-Vela, Sabela Fernández, Vicente Aldasoro, Cristina Luna-Gomez, Alfonso Corrales, Montserrat Corteguera, P. Vela-Casasempere, Elena Aurrecoechea, Antonio García
Publikováno v:
Oral Presentations.
Background Giant cell arteritis (GCA) can be refractory to corticosteroid therapy. Tocilizumab (TCZ) has been approved in the treatment of GCA. There are no studies comparing the efficacy and safety when using TCZ as monotherapy or in combination wit
Autor:
Roser Solans-Laqué, Susana Romero-Yuste, P. Vela-Casasempere, Raquel Dos-Santos, Marcelino Revenga, C. Hidalgo, Sara Manrique Arija, Carmen Larena, Elena Aurrecoechea, Miguel A. González-Gay, I. Villa-Blanco, Noelia Alvarez-Rivas, Beatriz Arca, Sabela Fernández, Carmen Ordas-Calvo, Ricardo Blanco, Eva Salgado-Pérez, Enrique Raya, María Álvarez del Buergo, Santos Castañeda, María Varela-García, Carles Galisteo, Juan Carlos Nieto, Francisco Navarro, Catalina Gomez-Arango, Toyos Sáenz de Miera, Eugenio de Miguel, Alfonso Corrales, Cristina Luna-Gomez, Ángel García-Manzanares, Francisco Ortiz-Sanjuán, Carmen Torres-Martín, A. Humbría, J Francisco, José Andrés Román-Ivorra, Clara Moriano, Luisa Marena Rojas, Vanesa Calvo-Río, Alejandro Olive, Rafael Melero, Antonio García, Elena Becerra-Fernández, Norberto Ortego, Monica Calderón-Goercke, Francisca Sivera, J. Luis Hernández, Montserrat Corteguera, Carlos Fernández-López, N. Fernández-Llanio, Natalia Palmou-Fontana, Diana Prieto-Peña, Pau Lluch, Carlos Vázquez, Javier Loricera, Arantxa Conesa, Javier Narváez, Eva Perez-Pampin, Carmen González-Vela, Vicente Aldasoro, Eva Galindez
Publikováno v:
Abstracts Accepted for Publication.
Background Recently, based on the GiACTA trial results, weekly subcutaneous Tocilizumab (TCZ) has been approved for the treatment of Giant Cell Arteritis (GCA). It has showed to be effective and safety. Objectives Our aim was to compare the efficacy